ICON Awarded Best CRO at World Vaccine Congress 2017
ICON recognised for continually setting standards of excellence in vaccine development
ICON Selected by ICHOM
ICON and ICHOM are creating the world’s first global healthcare outcomes benchmarking programme
Selected by the FDA to Validate Patient-Reported Outcome Endpoints
Research is being conducted in collaboration with the FNIH Biomarkers Consortium. More details enclosed.
ICON Honoured as Company of the Year at the Business & Finance Irish Business Awards
Award recognises ICON’s business leadership, growth, innovation and employee development
ICON Enhances Clinical Trial Feasibility & Capabilities with TriNetX
ICON applies real-world health research network to improve clinical development.
ICON Honoured as Contract Services Company at the Pharma Industry Awards
The Pharma Industry Awards celebrate the most original and innovative individuals and companies in the Irish Pharma sector.
ICON Completes the Acquisition of Clinical Research Management, Inc.
Acquisition extends ICON’s presence in the market for government sponsored research and enhances capabilities in Vaccines and Infectious Disease
ICON Forms Strategic Alliance With Boston Clinical Research Institute
Alliance Enhances ICON’s Scientific Expertise and Access to Investigators
ICON Reports Second Quarter 2016 Results
In the second quarter net revenue grew 5.7% year on year to $410.6 million.
ICON to Acquire Clinical Research Management, Inc.
ClinicalRM provide full service and functional research solutions to a broad range of US government agencies.